Ross has been an associate director in medicines evaluation for 5 years. In that time, he has led evaluations for a wide variety of topics, including treatments for COVID-19, CAR T-cell therapy, Alzheimer’s disease and spinal muscular atrophy. Before that Ross spent 5 years as a technical adviser and analyst at NICE and started his career in the Government Economic Service.